Zobrazeno 1 - 5
of 5
pro vyhledávání: '"792"'
Autor:
Lynn A. Sleeper, Bonnie A. Salbert, Jeffrey A. Towbin, Steven D. Colan, David M. Connuck, Jane Messere, Gerald F. Cox, Steven E. Lipshultz, James D. Wilkinson, April M. Lowe
Publikováno v:
American Heart Journal. 164:442-448
Background Studies of cardiomyopathy in children with Noonan syndrome (NS) have been primarily small case series or cross-sectional studies with small or no comparison groups. Methods We used the Pediatric Cardiomyopathy Registry database to compare
Autor:
Matthew R. Reynolds, David R. Holmes, Duane S. Pinto, Chunxue Shi, Joshua Walczak, Ronna H. Berezin, David J. Cohen
Publikováno v:
American heart journal. 154(6)
Background Sirolimus-eluting stents (SESs) were recently shown to be superior to vascular brachytherapy for the treatment of restenosis within a bare metal stent. No economic comparison of these alternative strategies has yet been reported. Methods W
Autor:
John F. Carlquist, Joseph B. Muhlestein, Benjamin D. Horne, Zachary P. Nicholas, Jeffrey L. Anderson
Publikováno v:
American heart journal. 154(5)
Coronary heart disease, including its clinical manifestation, myocardial infarction (MI), is a common, complex disease with a substantive genetic component. State-of-the-art genetic epidemiology evaluates thousands of single nucleotide polymorphisms
Autor:
Faye L. Lopez, Alvaro Alonso, Kim A. Williams, Tochi M. Okwuosa, Elsayed Z. Soliman, Keith C. Ferdinand
Publikováno v:
American Heart Journal. 169:155-161.e5
Background Left ventricular hypertrophy (LVH) is a major independent predictor of cardiovascular disease (CVD) survival and is more prevalent in blacks than whites. In a large biracial population, we evaluated the ability of electrocardiography (ECG)
Publikováno v:
American Heart Journal. 101:529-533
Twelve patients with severe chronic congestive heart failure (CHF) (NYHA class III and IV) resistant to digitalis and diuretics were treated with the postsynaptic alpha-blocking agent prazosin (PZ) (3 to 20 mg/day). In 11 patients oral PZ treatment w